PT-141 in Jacksonville, from $110 a vial.
Healing Advanced Solutions offers PT-141 in Jacksonville, FL at $110 for a take-home vial, prescribed and monitored by Catherine Seidle, APRN after a free consultation. PT-141, or bremelanotide, acts on desire pathways in the brain and is the same active ingredient as Vyleesi, which the FDA approved in 2019.
- Provider-prescribed
- COA-verified lots
- Traceable sourcing
FDA status. Peptides dispensed here are not FDA-approved drug products, and the FDA has not evaluated them for safety or effectiveness. PT-141 is prescribed only after a provider reviews your history.
What is PT-141?
PT-141, known generically as bremelanotide, is a synthetic peptide that acts on melanocortin receptors in the brain, the pathways involved in sexual desire. It is the same active ingredient as Vyleesi, which the FDA approved in 2019 for premenopausal women with low sexual desire. Because it works on desire in the brain rather than on blood flow, it is often tried when other options have fallen short. Here it is prescribed as a take-home vial after a free consultation and a review of your history.
PT-141 benefits and uses.
-
Low desire in women
The basis of its FDA approval. Two phase 3 trials in 1,267 premenopausal women found a measurable improvement in desire compared with placebo.
-
Libido in men
Men use it too. The large trials behind its approval were in women.
-
Acts on desire in the brain
It works through melanocortin receptors in the brain, a different route from blood-flow medications, and it is taken as needed before sexual activity.
- 1,267women in the two phase 3 trials behind its approval
- 2019the year FDA approved Vyleesi, the same active ingredient
- As neededtaken only before sexual activity
How does PT-141 work?
PT-141 activates melanocortin receptors, especially MC4R, in areas of the brain involved in sexual desire and arousal. That is a different route from erectile dysfunction medications, which act on blood flow. The approved product is used as needed before sexual activity rather than every day.
What does the research on PT-141 show?
- Human study
In the RECONNECT twin phase 3 randomized, placebo-controlled trials of 1,267 premenopausal women, bremelanotide produced a measurable improvement in desire, the basis of its 2019 approval. Kingsberg 2019
- Human study
A phase 2b trial in premenopausal women came before the phase 3 program. Clayton 2016
- Human study
An open-label extension enrolled 684 women for longer-term use. Simon 2019
- Human study
An integrated safety analysis of about 3,500 participants found nausea in 40.0% on bremelanotide against 1.3% on placebo. Clayton 2022
- Human study
Ambulatory monitoring found a small, temporary rise in blood pressure after a dose. White 2017
PT-141 side effects and safety.
- Nausea, the most common effect: 40% in the trials, usually with the first doses
- Flushing and headache
- Redness or irritation at the injection site
- A small, temporary rise in blood pressure after a dose
- Darkening of patches of skin with repeated use
These are from the approved product's trials and label. PT-141 is not used with uncontrolled high blood pressure or known heart disease, which is why your history is reviewed first.
Starting PT-141 in Jacksonville.
-
Free consultation
Ten to fifteen minutes by phone or video about what you want PT-141 for.
-
Your visit
Catherine Seidle, APRN reviews your history, and labs where they are needed.
-
Your take-home vial
Prescribed and dispensed with bacteriostatic water and syringes, ready to use at home.
-
Follow-up
Your dose and schedule are adjusted to how you respond.
- No gray-market or research-chemical vials
- A certificate of analysis with every vial
- Prescribed by a licensed provider
Comparing your options?
Common questions.
What is PT-141?
PT-141, or bremelanotide, is a peptide that acts on desire pathways in the brain. It is the same active ingredient as Vyleesi, which the FDA approved in 2019 for premenopausal women with low sexual desire.
Does PT-141 work?
In two phase 3 trials of 1,267 women, it produced a measurable improvement in desire compared with placebo. Men use it too, and the large trials were in women.
Does PT-141 work for men?
Men use it for libido, and it acts on the same brain pathways in men and women. The large trials behind its approval were in women.
What are the side effects of PT-141?
Nausea is the most common, in 40% of trial participants, usually with the first doses. Flushing, headache, injection-site reactions, a small temporary rise in blood pressure, and darkening of skin patches with repeated use are also on the label.
Is PT-141 FDA approved?
Its active ingredient is, as Vyleesi, approved in 2019 for premenopausal women with acquired low sexual desire. The take-home vial prescribed here is not the Vyleesi brand.
How is PT-141 taken?
It is a small injection under the skin, taken as needed before sexual activity rather than daily. Your dose is set by Catherine Seidle, APRN at your visit.
How much does PT-141 cost?
A take-home vial is $110, and it includes the bacteriostatic water and syringes. The consultation is free.
PT-141 vs Viagra: what is the difference?
Viagra and similar medications increase blood flow. PT-141 acts on desire pathways in the brain. They work differently, which is why your provider weighs your history before combining approaches.
This information is for general education and is not medical advice, a diagnosis, or a substitute for care from your provider.
Tell us the goal. Get a real answer.
Ten to fifteen minutes with our team. Tell us why PT-141 is on your radar, and we will help you decide whether it fits, and what the evidence actually supports.
We reply within one business day.